Recap: Collegium Pharmaceutical Q1 Earnings - Collegium Pharmaceutical (NASDAQ:COLL)

Collegium Pharmaceutical COLL reported its Q1 earnings results on Tuesday, May 10, 2022 at 04:00 PM.

Here's what investors need to know about the announcement.

Collegium Pharmaceutical missed estimated earnings by 53.33%, reporting an EPS of $0.42 versus an estimate of $0.9.

Revenue was down $3.97 million from the same period last year.

Last quarter the company missed on EPS by $1.55 which was followed by a 9.53% drop in the share price the next day.

Here's a look at Collegium Pharmaceutical's past performance:

Quarter	Q4 2021	Q3 2021	Q2 2021	Q1 2021
EPS Estimate	1.04		0.36	0.30
EPS Actual	-0.51	0.22	0.27	0.41
Revenue Estimate	81.61M	84.89M	84.77M	81.87M
Revenue Actual	27.36M	78.84M	82.94M	87.72M

To track all earnings releases for Collegium Pharmaceutical visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.